$3.32
-0.04-1.09%
At close: -
$3.32
0.000.00%
After Hours: 7:15 PM EDT
Comments
Loading...
Qualigen Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:QLGN | Benzinga
Qualigen Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 14
EPS
$-4.700
Quarterly Revenue
$0.00
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Qualigen Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| QLGN | Qualigen Therapeutics | -$23.50 | — | — | — | $0.00 | — | — | — | 04/07/2025 | Get Alert |
| QLGN | Qualigen Therapeutics | -$32.01 | — | -$4.70 | — | $0.00 | — | $0.00 | — | 11/14/2024 | Get Alert |
| QLGN | Qualigen Therapeutics | -$34.50 | — | -$10.00 | — | $1.63M | — | $0.00 | — | 08/14/2024 | Get Alert |
| QLGN | Qualigen Therapeutics | -$39.00 | — | -$17.50 | — | $1.61M | — | $0.00 | — | 07/02/2024 | Get Alert |
| QLGN | Qualigen Therapeutics | -$77.50 | -$26.00 | -$23.50 | 9.62% | $1.39M | — | $0.00 | — | 04/08/2024 | Get Alert |
| QLGN | Qualigen Therapeutics | -$50.00 | -$46.00 | -$32.00 | 30.43% | $1.44M | $500.00K | $0.00 | -100.00% | 11/14/2023 | Get Alert |
| QLGN | Qualigen Therapeutics | -$55.00 | -$26.00 | -$34.50 | -32.69% | $1.43M | $1.60M | $1.63M | 1.69% | 08/15/2023 | Get Alert |
| QLGN | Qualigen Therapeutics | -$60.00 | — | -$39.00 | — | $722.03K | $2.00M | $1.61M | -19.64% | 05/16/2023 | Get Alert |
| QLGN | Qualigen Therapeutics | -$100.00 | — | -$77.50 | — | $1.48M | — | $1.39M | — | 05/02/2023 | Get Alert |
| QLGN | Qualigen Therapeutics | -$50.00 | -$65.00 | -$50.00 | 23.08% | $1.16M | $1.62M | $1.44M | -11.05% | 11/15/2022 | Get Alert |
| QLGN | Qualigen Therapeutics | -$90.00 | — | -$55.00 | — | $1.12M | — | $1.43M | — | 08/16/2022 | Get Alert |
| QLGN | Qualigen Therapeutics | -$65.00 | — | -$60.00 | — | $1.90M | — | $722.03K | — | 05/13/2022 | Get Alert |
| QLGN | Qualigen Therapeutics | -$1.58K | -$85.00 | -$100.00 | -17.65% | $2.71M | $1.75M | $1.48M | -15.37% | 03/31/2022 | Get Alert |
| QLGN | Qualigen Therapeutics | $205.00 | -$95.00 | -$50.00 | 47.37% | $1.11M | $1.70M | $1.16M | -32.06% | 11/15/2021 | Get Alert |
| QLGN | Qualigen Therapeutics | -$205.00 | -$90.00 | -$90.00 | 0.00% | $837.71K | $1.60M | $1.12M | -30.13% | 08/17/2021 | Get Alert |
| QLGN | Qualigen Therapeutics | -$1.06K | — | -$65.00 | — | $904.07K | — | $1.90M | — | 05/14/2021 | Get Alert |
| QLGN | Qualigen Therapeutics | — | — | -$1.58K | — | — | — | $2.71M | — | 03/31/2021 | Get Alert |
| QLGN | Qualigen Therapeutics | — | -$65.00 | $205.00 | 415.38% | — | $2.00M | $1.11M | -44.60% | 03/31/2021 | Get Alert |
| QLGN | Qualigen Therapeutics | — | — | -$205.00 | — | — | — | $837.71K | — | 11/12/2020 | Get Alert |
| QLGN | Qualigen Therapeutics | — | — | -$1.06K | — | — | — | $904.07K | — | 08/14/2020 | Get Alert |
Qualigen Therapeutics (QLGN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2024-04-08 | $-23.50 | $-26.00 | 9.62 % |
| Q3 | 2023-11-14 | $-32.00 | $-46.00 | 30.4 % |
| Q2 | 2023-08-15 | $-34.50 | $-26.00 | -32.7 % |
| Q3 | 2022-11-15 | $-50.00 | $-65.00 | 23.1 % |
Qualigen Therapeutics (QLGN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2023-11-14 | $0 | $500.00K | -100.0 % |
| Q2 | 2023-08-15 | $1.63M | $1.60M | 1.69 % |
| Q1 | 2023-05-16 | $1.61M | $2.00M | -19.6 % |
| Q3 | 2022-11-15 | $1.44M | $1.62M | -11.1 % |
FAQ
When is Qualigen Therapeutics (NASDAQ:QLGN) reporting earnings?
Qualigen Therapeutics (QLGN) is scheduled to report earnings on April 7, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
What were the latest earnings per share (EPS) for Qualigen Therapeutics (NASDAQ:QLGN)?
The Actual EPS was $-4.70, which missed the estimate of $0.00.
What were Qualigen Therapeutics’s (NASDAQ:QLGN) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.